A phase II study of high dose ARA-C and mitoxantrone for treatment of relapsed or refractory adult acute lymphoblastic leukemiaPeter J. Rosen, Frederick R. Appelbaum, David R. Head et al.|Leukemia Research|2000Cited by 20